SteadyMed Reports Recent Developments and Third Quarter 2015 Financial Results
12. November 2015 16:05 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value...
SteadyMed Announces Closing of Initial Public Offering
25. März 2015 14:26 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the closing of its initial public offering of 4,700,000 ordinary shares at a...
SteadyMed Raises $12.2 Million in Equity Financing
29. Januar 2015 08:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address...